Recent molecular studies have revealed biological subgroups of infant gliomas with different genetic alterations and outcome.3,4 The present case belongs to a group of hemispheric RTK-driven gliomas harboring ALK/ROS1/NTRK/MET alterations. The gene discussed is ROS1; the disease is central nervous system cancer.